CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 18,889 shares at $32.89 ($621,259)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 17,000 shares at $32.35 ($549,950)
- 4 Option exercise Director acquired 64,508 shares (option exercise)
- 4 Planned sale CHIEF OPERATING OFFICER sold 18,900 shares at $28.72 ($542,808)
- 4 Option exercise Director acquired 1,101 shares (option exercise)
- 4 Planned sale CHIEF OPERATING OFFICER sold 17,300 shares at $28.28 ($489,244)
- 4 Open-market sale Director sold 27,448 shares at an average $30.35 ($833,001)
- 4 Planned sale CHIEF OPERATING OFFICER sold 70,867 shares at an average $30.48 ($2,160,035)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Grant or award Director acquired 16,794 shares (grant or award)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Option exercise Director acquired 3,173 shares (option exercise)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 15,211 shares at $28.75 ($437,316)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 27,594 shares at $29.02 ($800,778)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 18,299 shares at $28.80 ($527,011)
- 4 Planned sale CHAIRMAN & CEO sold 86,270 shares at an average $27.24 ($2,349,981)
- 4 Planned sale CHAIRMAN & CEO sold 2,349 shares at $27.02 ($63,470)
Page 5 of 20 · 386 filings